HPV16 seropositivity relatively common prior to diagnosis of anal cancer
the ONA take:
According to a new study published online in the Journal of Clinical Oncology, researchers from the National Cancer Institute in Bethesda, Maryland, have found that human papillomavirus (HPV) type 16 (HPV16) seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.
Because the European Prospective Investigation Into Cancer and Nutrition Study found that HPV16 E6 seropositivity was present in people more than 10 years prior to being diagnosed with oropharyngeal cancer, researchers sought to investigate the extent to which HPV16 E6 seropositivity was present before the diagnosis of anogenital cancers.
Researchers identified 400 cases of anogenital cancers and 718 matched control in which prediagnostic blood samples were available. Results showed that 29.2% of those who later developed anal cancer had HPV16 E6 seropositivity compared with 0.6% of controls (OR = 75.9).
HPV16 E6 seropositivity was less common in patients who later developed cervical, penilee, vaginal, and vulvar cancers. HPV16 E6 seropositivity was more common in blood samples drawn closer in time to diagnosis.
HPV16 seropositivity is relatively common in people prior to receiving a diagnosis of anal cancer.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|